Therapeutic enzyme formulations and uses thereof

Details for Australian Patent Application No. 2005239985 (hide)

Owner The Board of Trustees of the Leland Stanford Junior University Alvine Pharmaceuticals, Inc.

Inventors Bethune, Michael; Shan, Lu; Khosla, Chaitan; Gass, Jonathan

Agent FB Rice

Pub. Number AU-B-2005239985

PCT Pub. Number WO2005/107786

Priority 10/969,314 19.10.04 US; 60/565,668 26.04.04 US

Filing date 23 February 2005

Wipo publication date 17 November 2005

Acceptance publication date 12 August 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/48 (2006.01) Medicinal preparations containing peptides

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/107786 Priority application(s): WO2005/107786

17 May 2007 Assignment before Grant

  The Board of Trustees of the Leland Stanford Junior University; Celiac Sprue Research Foundation The application has been assigned to The Board of Trustees of the Leland Stanford Junior University; Alvine Pharmaceuticals, Inc.

12 August 2010 Application Accepted

  Published as AU-B-2005239985

9 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005239989-Naltrexone long acting formulations and methods of use

2005239984-Use of equol for treating skin diseases